Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/31/2002WO2002086162A1 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device
10/31/2002WO2002086157A2 Use of semaphorin 3a for diagnosing and treating cancer, especially prostate cancer
10/31/2002WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002WO2002086154A2 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
10/31/2002WO2002086152A1 Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phophodiesterase 4 (pde4) subtype b and their use for the screening of pde4 subtype-specific modulators
10/31/2002WO2002086149A2 Diagnosis by sensing volatile components
10/31/2002WO2002086148A1 Particle based assay system
10/31/2002WO2002086147A2 Single nucleotide polymorphisms diagnostic for schizophrenia
10/31/2002WO2002086134A2 Buffer solution for electroporation and a method comprising the use of the same
10/31/2002WO2002086131A1 Gene expression controlling unit and utilization thereof
10/31/2002WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002WO2002086120A1 Yeast expressing antibody-binding protein on cell surface layer and utilization thereof
10/31/2002WO2002086115A1 Active site inactivators
10/31/2002WO2002086113A2 Enzyme and snp marker for disease
10/31/2002WO2002086107A2 A method for differentiating stem cells into insulin-producing cells
10/31/2002WO2002086101A2 Core-glycosylated hcv envelope proteins
10/31/2002WO2002086100A2 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002WO2002086097A2 Methods for identifying the target of a compound which inhibits cellular proliferation
10/31/2002WO2002086093A2 Methods of using a hyaluronan receptor
10/31/2002WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002WO2002086086A2 Methods to identify agents that bind the flap-tip helix of rna polymerase
10/31/2002WO2002086085A2 Human timp-1 antibodies
10/31/2002WO2002086082A2 Isolation of neural stem cells using gangliosides and other surface markers
10/31/2002WO2002086081A2 Methods and systems for identifying proteins
10/31/2002WO2002086079A2 T1r3 a novel taste receptor
10/31/2002WO2002086071A2 Cancer-testis antigens
10/31/2002WO2002086070A2 Binding molecules for fc-region polypeptides
10/31/2002WO2002086069A2 Secreted proteins
10/31/2002WO2002086065A2 Induction of apoptosis by cellular stress
10/31/2002WO2002086062A2 Methods of screening for compounds that modulate hormone receptor activity
10/31/2002WO2002086055A1 Method for minimizing optical interference during antibiotic susceptibility readings in a microbiological analyzer
10/31/2002WO2002086054A1 Method for maintaining test integrity within a microbiological test array
10/31/2002WO2002086051A2 Nucleic acid analysis by mass differentiable oligomers
10/31/2002WO2002086030A1 Selection of materials to test for and/or remove drag reducer additive in liquid hydrocarbon fuels
10/31/2002WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002WO2002085936A1 Mutants of green fluorescent protein
10/31/2002WO2002085932A2 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002WO2002085926A2 Method for producing stable, regeneratable antibody arrays
10/31/2002WO2002085791A2 Pcr-based monitoring in wastewater biotreatment systems
10/31/2002WO2002085667A2 Three cube fret method (33-fret) for detecting fluorescence energy transfer
10/31/2002WO2002085519A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
10/31/2002WO2002085410A2 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
10/31/2002WO2002085404A1 Lkb1-binding proteins
10/31/2002WO2002085306A2 Use of follistatin to increase muscle mass
10/31/2002WO2002085298A2 Method for detecting breast cancer cells
10/31/2002WO2002085295A2 Methods and compositions for the modulation of biofilm formation
10/31/2002WO2002085290A2 Edg : modulators of lymphocyte activation and migration
10/31/2002WO2002085285A2 Methods and reagents for regulating bone and cartilage formation
10/31/2002WO2002085209A1 Measurement of patient data requiring operator and patient identification
10/31/2002WO2002085207A1 Multiple function airway adapter
10/31/2002WO2002085185A2 Hydrophilic diagnostic devices
10/31/2002WO2002085116A1 Sprr1a and axonal regeneration
10/31/2002WO2002085093A2 Replikin peptides and uses thereof
10/31/2002WO2002071062A8 Diagnosis and treatment of inflammation and hyperactive immune conditions
10/31/2002WO2002070737A8 Compositions and methods relating to osteoarthritis
10/31/2002WO2002066982A8 Analysis of modification and demodification of proteins with ubiquitin-related proteins by means of fret (fluorescence resonance energy transfer)
10/31/2002WO2002066960A9 Drug discovery system with auto-sampler for multicellular organisms in a sorting flow cytometer
10/31/2002WO2002066681A9 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
10/31/2002WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002WO2002064022A3 Therapy for cerebral vasospasm
10/31/2002WO2002063273A3 Device and method for evaluating platelets
10/31/2002WO2002062207A3 Myeloperoxidase, a risk indicator for cardiovascular disease
10/31/2002WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002WO2002061048A3 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
10/31/2002WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002WO2002055680A3 Morphometric tissue or cell preparation
10/31/2002WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002WO2002054066A3 Non-apoptotic forms of cell death and methods of modulation
10/31/2002WO2002052271A3 Inverse labeling method for the rapid identification of marker/target proteins
10/31/2002WO2002046219A3 Rho-gtpase activating proteins and methods related thereto
10/31/2002WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002WO2002043575A3 Zinc alpha-2-glycoprotein as indicator of cancer
10/31/2002WO2002042489A9 Methods involving a t cell protein tyrosine phosphatase
10/31/2002WO2002042455A3 Modifier of organelle metalbolism
10/31/2002WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002WO2002031476A3 Methods and apparatus for downhole fluids analysis
10/31/2002WO2002028910A3 Geometrically efficient particle agglutination, particularly to detect low affinity binding
10/31/2002WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002WO2002022860A9 A system and method for identifying t cell and other epitopes and the like
10/31/2002WO2002014499A3 Claudin polypeptides
10/31/2002WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002WO2002000250A3 Hiv-1 vaccines and screening methods therefor
10/31/2002WO2001094635A3 Integrated active flux microfluidic devices and methods
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002WO2001055736A9 Device for use in monitoring particulate flow
10/31/2002WO2001055701A9 System and method for the analysis of bodily fluids
10/31/2002WO2001054814A9 Compositions and methods for performing biological reactions
10/31/2002WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002WO2000034394A3 Pyridine dyes and quinoline dyes used as markers for biomolecules, polymers, medicaments, and particles
10/31/2002US20020162129 Prevention and treatment of alzheimer's disease
10/31/2002US20020162126 Methods and compositions for RNA interference
10/31/2002US20020161540 Device for evaluating internal quality of vegetable or fruit, method for warm-up operation of the device, and method for measuring internal quality
10/31/2002US20020161289 Detector array for optical spectrographs
10/31/2002US20020161288 Real time self-adjusting calibration algorithm
10/31/2002US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
1 ... 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 ... 3937